CARCINOID TUMOR
Clinical trials for CARCINOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new CARCINOID TUMOR trials appear
Sign up with your email to follow new studies for CARCINOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…
Matched conditions: CARCINOID TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Promising drug shows potential to stall neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) better than a placebo. About 298 adults whose cancer worsened after previous treatments will receive either cabozantinib or a dummy pill. The goal is …
Matched conditions: CARCINOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New CT technique could spot hidden gut tumors
Diagnosis OngoingThis study tests whether a special type of CT scan, called dual energy CT, can better detect carcinoid tumors in the digestive system. About 71 adults with signs or a diagnosis of these tumors will get this scan during a routine imaging visit. The goal is to see if the new techni…
Matched conditions: CARCINOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC